Healthcare Pharmaceutical manufacturing Prescription Retail 
PM360
NOVEMBER 14, 2023
In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. retail pharmacies to access a 30-day supply of Lantus for only $35. for only $35. References: 1.
European Pharmaceutical Review
NOVEMBER 8, 2022
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.
Expert insights. Personalized for you.
52 
Let's personalize your content